Quarterly Share-based Compensation rose 6.67% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.0 million through Dec 2025, up 23.64% year-over-year, with the annual reading at $68.0 million for FY2025, 23.64% up from the prior year.
Share-based Compensation hit $16.0 million in Q4 2025 for Elanco Animal Health, down from $17.0 million in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $20.0 million in Q2 2025 to a low of $9.0 million in Q2 2023.
Historically, Share-based Compensation has averaged $14.7 million across 5 years, with a median of $15.0 million in 2021.
Biggest five-year swings in Share-based Compensation: skyrocketed 100.0% in 2021 and later crashed 47.06% in 2023.
Year by year, Share-based Compensation stood at $18.0 million in 2021, then fell by 16.67% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then increased by 6.67% to $16.0 million in 2025.
Business Quant data shows Share-based Compensation for ELAN at $16.0 million in Q4 2025, $17.0 million in Q3 2025, and $20.0 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value